Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the MD Anderson Prognostic Index
Background Locoregional recurrence after neoadjuvant chemotherapy for primary breast cancer is associated with poor prognosis. It is essential to identify patients at high risk of locoregional recurrence who may benefit from extended local therapy. Here, we examined the prediction accuracy and clini...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 31, 2019
|
| In: |
PLOS ONE
Year: 2019, Jahrgang: 14, Heft: 1 |
| ISSN: | 1932-6203 |
| DOI: | 10.1371/journal.pone.0211337 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1371/journal.pone.0211337 Verlag: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211337 
|
| Verfasserangaben: | Laura L. Michel, Laura Sommer, Rosa González Silos, Justo Lorenzo Bermejo, Alexandra von Au, Julia Seitz, André Hennigs, Katharina Smetanay, Michael Golatta, Jörg Heil, Florian Schütz, Christof Sohn, Andreas Schneeweiss, Frederik Marmé |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1678394181 | ||
| 003 | DE-627 | ||
| 005 | 20230427193645.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191008s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pone.0211337 |2 doi | |
| 035 | |a (DE-627)1678394181 | ||
| 035 | |a (DE-599)KXP1678394181 | ||
| 035 | |a (OCoLC)1341244999 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Michel, Laura L. |d 1984- |e VerfasserIn |0 (DE-588)1018124888 |0 (DE-627)680395857 |0 (DE-576)355064529 |4 aut | |
| 245 | 1 | 0 | |a Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer |b clinical utility of the MD Anderson Prognostic Index |c Laura L. Michel, Laura Sommer, Rosa González Silos, Justo Lorenzo Bermejo, Alexandra von Au, Julia Seitz, André Hennigs, Katharina Smetanay, Michael Golatta, Jörg Heil, Florian Schütz, Christof Sohn, Andreas Schneeweiss, Frederik Marmé |
| 264 | 1 | |c January 31, 2019 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.10.2019 | ||
| 520 | |a Background Locoregional recurrence after neoadjuvant chemotherapy for primary breast cancer is associated with poor prognosis. It is essential to identify patients at high risk of locoregional recurrence who may benefit from extended local therapy. Here, we examined the prediction accuracy and clinical applicability of the MD Anderson Prognostic Index (MDAPI). Methods Prospective clinical data from 456 patients treated between 2003 and 2011 was analyzed. The Kaplan-Meier method was used to examine the probabilities of locoregional recurrence, local recurrence and distant metastases according to individual prognosis score, stratified by type of surgery (breast conserving therapy or mastectomy). The possible confounding of the relationship between recurrence risk and MDAPI by established risk factors was accounted for in multiple survival regression models. To define the clinical utility of the MDAPI we analyzed its performance to predict locoregional recurrence censoring patients with prior or simultaneous distant metastases. Results Mastectomized patients (42% of the patients) presented with more advanced tumor stage, lower tumor grade, hormone-receptor positive disease and consequently lower pathological complete response rates. Only a few patients presented with high-risk scores (2,7% MDAPI≥3). All patients with high-risk MDAPI score (MDAPI ≥3) who developed locoregional recurrence were simultaneously affected by distant metastases. Conclusion Our data do not support a clinical utility of the MDAPI to guide local therapy. | ||
| 650 | 4 | |a Breast cancer | |
| 650 | 4 | |a Cancer chemotherapy | |
| 650 | 4 | |a Cancer treatment | |
| 650 | 4 | |a Lymph nodes | |
| 650 | 4 | |a Mastectomy | |
| 650 | 4 | |a Radiation therapy | |
| 650 | 4 | |a Surgical and invasive medical procedures | |
| 650 | 4 | |a Surgical oncology | |
| 700 | 1 | |a Sommer, Laura |d 1991- |e VerfasserIn |0 (DE-588)1188894595 |0 (DE-627)1667756141 |4 aut | |
| 700 | 1 | |a González Silos, Rosa |e VerfasserIn |0 (DE-588)1121144195 |0 (DE-627)874011930 |0 (DE-576)480745471 |4 aut | |
| 700 | 1 | |a Lorenzo Bermejo, Justo |d 1972- |e VerfasserIn |0 (DE-588)124754619 |0 (DE-627)706705572 |0 (DE-576)294483632 |4 aut | |
| 700 | 1 | |a Au, Alexandra von |d 1985- |e VerfasserIn |0 (DE-588)1022333909 |0 (DE-627)716953366 |0 (DE-576)362850666 |4 aut | |
| 700 | 1 | |a Seitz, Julia |d 1981- |e VerfasserIn |0 (DE-588)1127256173 |0 (DE-627)88170623X |0 (DE-576)485156679 |4 aut | |
| 700 | 1 | |a Hennigs, André |e VerfasserIn |0 (DE-588)1077795238 |0 (DE-627)837512395 |0 (DE-576)446682780 |4 aut | |
| 700 | 1 | |a Smetanay, Katharina |d 1982- |e VerfasserIn |0 (DE-588)140122036 |0 (DE-627)616034857 |0 (DE-576)314686452 |4 aut | |
| 700 | 1 | |a Golatta, Michael |d 1974- |e VerfasserIn |0 (DE-588)132350386 |0 (DE-627)521535727 |0 (DE-576)299091392 |4 aut | |
| 700 | 1 | |a Heil, Jörg |d 1978- |e VerfasserIn |0 (DE-588)132580187 |0 (DE-627)52396160X |0 (DE-576)299238679 |4 aut | |
| 700 | 1 | |a Schütz, Florian |d 1972- |e VerfasserIn |0 (DE-588)12303387X |0 (DE-627)082307229 |0 (DE-576)293528810 |4 aut | |
| 700 | 1 | |a Sohn, Christof |d 1961- |e VerfasserIn |0 (DE-588)131349287 |0 (DE-627)507642902 |0 (DE-576)298422255 |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Marmé, Frederik |d 1974- |e VerfasserIn |0 (DE-588)132561972 |0 (DE-627)52394893X |0 (DE-576)299226549 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PLOS ONE |d San Francisco, California, US : PLOS, 2006 |g 14(2019,1) Artikel-Nummer e0211337, 11 Seiten |h Online-Ressource |w (DE-627)523574592 |w (DE-600)2267670-3 |w (DE-576)281331979 |x 1932-6203 |7 nnas |a Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer clinical utility of the MD Anderson Prognostic Index |
| 773 | 1 | 8 | |g volume:14 |g year:2019 |g number:1 |g extent:11 |a Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer clinical utility of the MD Anderson Prognostic Index |
| 856 | 4 | 0 | |u https://doi.org/10.1371/journal.pone.0211337 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211337 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191008 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 132561972 |a Marmé, Frederik |m 132561972:Marmé, Frederik |d 910000 |d 910400 |d 50000 |e 910000PM132561972 |e 910400PM132561972 |e 50000PM132561972 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 14 |y j | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 13 | ||
| 998 | |g 131349287 |a Sohn, Christof |m 131349287:Sohn, Christof |d 910000 |d 910400 |e 910000PS131349287 |e 910400PS131349287 |k 0/910000/ |k 1/910000/910400/ |p 12 | ||
| 998 | |g 12303387X |a Schütz, Florian |m 12303387X:Schütz, Florian |d 910000 |d 910400 |d 50000 |e 910000PS12303387X |e 910400PS12303387X |e 50000PS12303387X |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 11 | ||
| 998 | |g 132580187 |a Heil, Jörg |m 132580187:Heil, Jörg |d 910000 |d 910400 |e 910000PH132580187 |e 910400PH132580187 |k 0/910000/ |k 1/910000/910400/ |p 10 | ||
| 998 | |g 132350386 |a Golatta, Michael |m 132350386:Golatta, Michael |d 910000 |d 910400 |e 910000PG132350386 |e 910400PG132350386 |k 0/910000/ |k 1/910000/910400/ |p 9 | ||
| 998 | |g 140122036 |a Smetanay, Katharina |m 140122036:Smetanay, Katharina |d 910000 |d 910400 |e 910000PS140122036 |e 910400PS140122036 |k 0/910000/ |k 1/910000/910400/ |p 8 | ||
| 998 | |g 1077795238 |a Hennigs, André |m 1077795238:Hennigs, André |d 910000 |d 910400 |e 910000PH1077795238 |e 910400PH1077795238 |k 0/910000/ |k 1/910000/910400/ |p 7 | ||
| 998 | |g 1127256173 |a Seitz, Julia |m 1127256173:Seitz, Julia |d 910000 |d 910400 |e 910000PS1127256173 |e 910400PS1127256173 |k 0/910000/ |k 1/910000/910400/ |p 6 | ||
| 998 | |g 1022333909 |a Au, Alexandra von |m 1022333909:Au, Alexandra von |d 910000 |d 910400 |e 910000PA1022333909 |e 910400PA1022333909 |k 0/910000/ |k 1/910000/910400/ |p 5 | ||
| 998 | |g 124754619 |a Lorenzo Bermejo, Justo |m 124754619:Lorenzo Bermejo, Justo |d 910000 |d 999701 |e 910000PL124754619 |e 999701PL124754619 |k 0/910000/ |k 1/910000/999701/ |p 4 | ||
| 998 | |g 1121144195 |a González Silos, Rosa |m 1121144195:González Silos, Rosa |d 910000 |d 999701 |e 910000PG1121144195 |e 999701PG1121144195 |k 0/910000/ |k 1/910000/999701/ |p 3 | ||
| 998 | |g 1188894595 |a Sommer, Laura |m 1188894595:Sommer, Laura |d 910000 |d 910400 |e 910000PS1188894595 |e 910400PS1188894595 |k 0/910000/ |k 1/910000/910400/ |p 2 | ||
| 998 | |g 1018124888 |a Michel, Laura L. |m 1018124888:Michel, Laura L. |d 910000 |d 910100 |e 910000PM1018124888 |e 910100PM1018124888 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1678394181 |e 3520127016 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"11 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1678394181"],"doi":["10.1371/journal.pone.0211337"]},"relHost":[{"note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"id":{"zdb":["2267670-3"],"issn":["1932-6203"],"eki":["523574592"]},"part":{"text":"14(2019,1) Artikel-Nummer e0211337, 11 Seiten","volume":"14","year":"2019","extent":"11","issue":"1"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"PLOS ONE","title":"PLOS ONE"}],"origin":[{"publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","dateIssuedKey":"2006","dateIssuedDisp":"2006-","publisher":"PLOS ; PLoS"}],"name":{"displayForm":["Public Library of Science"]},"corporate":[{"role":"isb","display":"Public Library of Science"}],"pubHistory":["1.2006 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"disp":"Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer clinical utility of the MD Anderson Prognostic IndexPLOS ONE","recId":"523574592"}],"note":["Gesehen am 24.10.2019"],"person":[{"role":"aut","family":"Michel","display":"Michel, Laura L.","given":"Laura L."},{"role":"aut","display":"Sommer, Laura","given":"Laura","family":"Sommer"},{"role":"aut","family":"González Silos","given":"Rosa","display":"González Silos, Rosa"},{"family":"Lorenzo Bermejo","display":"Lorenzo Bermejo, Justo","given":"Justo","role":"aut"},{"role":"aut","given":"Alexandra von","display":"Au, Alexandra von","family":"Au"},{"display":"Seitz, Julia","given":"Julia","family":"Seitz","role":"aut"},{"family":"Hennigs","display":"Hennigs, André","given":"André","role":"aut"},{"role":"aut","family":"Smetanay","given":"Katharina","display":"Smetanay, Katharina"},{"role":"aut","given":"Michael","display":"Golatta, Michael","family":"Golatta"},{"family":"Heil","display":"Heil, Jörg","given":"Jörg","role":"aut"},{"role":"aut","family":"Schütz","given":"Florian","display":"Schütz, Florian"},{"family":"Sohn","given":"Christof","display":"Sohn, Christof","role":"aut"},{"role":"aut","family":"Schneeweiss","display":"Schneeweiss, Andreas","given":"Andreas"},{"role":"aut","family":"Marmé","given":"Frederik","display":"Marmé, Frederik"}],"recId":"1678394181","origin":[{"dateIssuedDisp":"January 31, 2019","dateIssuedKey":"2019"}],"name":{"displayForm":["Laura L. Michel, Laura Sommer, Rosa González Silos, Justo Lorenzo Bermejo, Alexandra von Au, Julia Seitz, André Hennigs, Katharina Smetanay, Michael Golatta, Jörg Heil, Florian Schütz, Christof Sohn, Andreas Schneeweiss, Frederik Marmé"]},"language":["eng"],"title":[{"title":"Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer","subtitle":"clinical utility of the MD Anderson Prognostic Index","title_sort":"Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer"}]} | ||
| SRT | |a MICHELLAURPREDICTION3120 | ||